NASDAQ OMX

Zoom Runs Faster on Aryaka, Providing Faster Video and Web Conferencing for JAS Forwarding Worldwide

Del

MILPITAS, Calif., 2017-02-07 15:00 CET (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, announced today that JAS Forwarding Worldwide, one of the global leaders in freight forwarding and logistics, is using Aryaka’s global SD-WAN solution to speed up the performance and improve the quality of Zoom’s video conferencing service for executives and employees around the world.

“Once we put Zoom and Aryaka together, it allowed us to connect our global offices more easily. The world just became much smaller,” explained Mark Baker, CIO of JAS Forwarding Worldwide.

With over 240 offices in 80 countries worldwide, JAS needed a video conferencing solution to enable collaboration between globally distributed employees.

“We did have some high-end video conferencing services already in place,” explained Baker, “and we were able to replace them with Zoom. But it was only by using Aryaka, we were able to achieve the results we were looking for on a global scale.”

Zoom provides JAS with a cloud-based solution with a rich feature-set – one that supports both large conference calls and webinar capabilities. The Zoom solution scales easily; supports multiple visual mediums like phones, laptops, and desktops; and is accessible in the cloud, providing flexibility and easy manageability. The solution also comes at a lower total cost of ownership compared to competing solutions with similar functionality.

Yet using Zoom over the Internet still provided a challenge for JAS. They faced performance issues between their globally distributed offices for real-time voice and video traffic. Their legacy Internet-based network failed to meet quality expectations, resulting in frequent disconnects during video conferencing calls.

“Our employees are based in offices all across the globe, and as a logistics industry leader, efficient communication and collaboration between geographically distributed teams are key to ensuring continuous business productivity,” said Baker. “The main challenge we faced with Zoom was that it uses the public Internet by default, but the Internet is usually slow and inconsistent, which causes frustration for our employees using Internet-based applications.” 

To solve this challenge, JAS Forwarding Worldwide deployed Aryaka’s global SD-WAN to provide a high-performance network for unified communications and collaboration over Zoom and saw almost instantaneous improvement in audio and video quality, as well as delivery, over the video conferencing platform globally.

“All it took was a phone call to Aryaka, and within just minutes, the network was up and ready for all traffic from Zoom. We experienced better-than-MPLS video conferencing quality with Aryaka at a fraction of the cost. Not only did end users stop complaining about voice and video quality issues, the usage of the Zoom platform within JAS started to rise,” said Baker.

"Aryaka’s Global SD-WAN is uniquely designed to provide the best performance when delivering enterprise voice and video over long distances, such as for Zoom’s real-time collaboration applications,” said Shawn Farshchi, President and CEO of Aryaka. “Our network is purpose-built to enable unified communications and collaboration on a global scale."

Aryaka’s global SD-WAN enabled JAS to deploy the Zoom video conferencing solution globally and avoid duplicate investments in competing solutions, such as Cisco TelePresence, in multiple offices.

“Our top executives would, in the past, travel to regional offices to conduct quarterly business reviews,” added Baker. “Now they can do monthly business reviews over the Zoom video conferencing platform itself!”

About Aryaka

Aryaka is transforming how global enterprises connect sites and users worldwide, and use mission-critical applications to support modern business execution demands. Aryaka’s Global SD-WAN combines a purpose-built private network, SD-WAN, optimization and acceleration techniques, connectivity to cloud platforms, and network visibility in a single solution that is delivered as a service.

To learn more, visit www.aryaka.com. Follow us on TwitterFacebookYouTube and LinkedIn.

         Aryaka Media Contact
         Shehzad Karkhanawala
         Public Relations Manager
         Aryaka
         408-273-8420
         pr@aryaka.com

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer18.10.2017 16:53Pressemelding

AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan liposome injection) and 5-fluorouracil/folinic acid in combination with MABp1 in a cohort of patients with advanced pancreatic adenocarcinoma and cachexia. The patient has begun treatment at Cedars-Sinai Medical Center under the care of Dr. Andrew Hendifar, the Study's Principle Investigator, Medical Oncology lead for the Gastrointestinal Disease Research Group and Co-Director of Pancreas Oncology at Cedars-Sinai. A total of 16 patients are expected to be enrolled in the study. Dr. Hendifar commented, "We are excited to enroll our first patient in this novel combinatorial therapy for the treatment of advanced pancreatic cancer and cachexia. This is the first attempt to add an anti-inflammatory therapy to standard chemotherapy in an effort to improve the performanc

Nasdaq and SGX Establish Collaborative Listings Agreement18.10.2017 15:42Pressemelding

NEW YORK and SINGAPORE, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Nasdaq Inc. (Nasdaq:NDAQ) and Singapore Exchange (SGX) today announced the signing of a collaborative agreement in a move to leverage their strengths as two of the leading listings venues in the U.S. and Asia respectively. The new agreement seeks to enhance the channels available for companies to access capital market funding and enhance their corporate profile in both markets. As part of this agreement, Nasdaq and SGX -- who also share a successful, long-term market technology relationship -- are currently exploring the demand among corporates for a concurrent or sequential listing on both exchanges. Nasdaq and SGX are committed to supporting companies that are interested in pursuing this route. "The business landscape today is borderless," said Loh Boon Chye, CEO, SGX. "Fast-growing Asian companies looking to tap the capital markets can choose to list on SGX on Asian home ground, and embark on a listing on Nasdaq

Colliers International Expands in Washington, D.C.18.10.2017 14:30Pressemelding

Acquisition of Beltway Real Estate Services Firm Strengthens Ongoing Commitment to the Region TORONTO and WASHINGTON, Oct.  18, 2017  (GLOBE NEWSWIRE) -- Leading global commercial real estate services firm Colliers International Group Inc. (NASDAQ:CIGI)(TSX:CIGI) announced today the acquisition of leading tenant representation advisory firm Serten Advisors. With its office in Tysons Corner, the firm serves global, national, and regional clients with a highly skilled and experienced team of professionals that have more than 100 years of combined experience. "This strategic acquisition positions Colliers to gain additional market share and win new business in the vibrant and competitive Suburban DC markets," said Marty Pupil, Colliers International President | U.S. Brokerage. "Adding Steve and Paul and the rest of their talented leadership team to our existing group of professionals in the region will further position Colliers as the commercial real estate services firm of

InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC18.10.2017 14:00Pressemelding

InSphero AG / InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. New 3D InSight(TM) Human Liver Fibrosis Model represents a powerful tool for screening efficacy and safety of anti-fibrotic drugs in vitro. Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data characterizing and demonstrating the utility of its new 3D InSight(TM) Human Liver Fibrosis Model for screening efficacy of anti-fibrotic drugs.  The findings will be presented at oral and poster presentations this Friday at the annual meeting of the American Association for the Study of Liver Disease (AASLD) Conference in Washington, DC.  Anti-fibrotic therapi

Kofax Wins "Most Innovative Solution for Banking Customer Authentication" Award for Third Consecutive Year18.10.2017 08:00Pressemelding

Grand Prix Banque & Innovation Honor Recognizes Kofax Mobile ID Customer Onboarding Solution and its Anti-Fraud Capabilities IRVINE, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Kofax ®, a leading provider of software to simplify and transform the First Mile(TM) of business, today announced that Kofax Mobile ID(TM) has won "Most Innovative Solution for Banking Customer Authentication" in the 2017 Grand Prix Banque & Innovation Awards in Paris, France. Now in its fourth year, the Awards identify excellence and innovation in the banking sector. The program acknowledges technology companies that have launched and implemented the most outstanding banking-related software solutions, initiatives and projects in France over the past twelve months. This award highlights the new facial recognition and ID verificationfeatures of Kofax Mobile ID that determine the authenticity and validity of identification documents and their holders.  

World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer18.10.2017 06:25Pressemelding

YOKOHAMA, Japan, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The final press conference from the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new advancements surrounding the discovery of PD-1 and PD-L1, including a discussion from the researcher credited with discovering PD-1, as well as interventions to prevent lung cancer and improve quality of life for lung cancer patients. Innovations in lung cancer treatment linked to the discovery of PD-1 Prof. Tasuku Honjo of Japan, who was the first to identify PD-1 in 1992, shared an update on how PD-1 blockers have been widely used to treat many types of cancers. After decades of study, research into PD-1 has led to breakthrough immunotherapy treatments that are being hailed as a "penicillin moment" in cancer treatment. "I believe that, just as a number of antibiotics developed in the wake of the discovery of penicillin now p

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom